Skip to main content
. 2020 Oct 19;13(10):318. doi: 10.3390/ph13100318

Table 1.

Results of in vitro cholinesterases inhibitory assay of 2-(hydroxy-(3-nitrophenyl)methyl)cyclopentanone.

Samples Conc. (µg/mL) Acetylcholinesterase (AChE) Buterylcholinesterase (BChE)
Inhibition (%) IC50 µg/mL Inhibition (%) IC50 µg/mL
3NCP 07.8
15.6
16.17 ± 1.53
25.0 ± 5.0 *
16.17 66.0 ± 2.65
224.0 ± 5.29
20.51
31.25 45.7 ± 4.04 44.3 ± 6.03
62.5 57.0 ± 3.0 55.0 ± 4.36 *
125 65.3 ± 4.16 65.8 ± 1.89
250 72.3 ± 3.06 71.0 ± 5.57
500 77.0 ± 3.0 76.0 ± 1.73
1000 84.9 ± 5.0 86.3 ± 5.51
Galantamine 07.8
15.6
11.3 ± 1.6
36.0 ± 2.0
13.12 16.0 ± 2.0
31.7 ± 5.77
14.43
31.25 54.0 ± 3.0 57.0 ± 2.0
62.5 62.0 ± 2.0 70.0 ± 5.0
125 71.0 ± 2.2 75.0 ± 5.0
250 77.0 ± 3.0 80.0 ± 4.5
500 84.7 ± 2.0 88.0 ± 4.0
1000 88.7 ± 4.15 91.3 ± 2.31

It has concentration-dependent inhibitory properties against these enzymes. Inhibition was observed as 16.17% and 6% at 7.8 µg/mL, while it was 84.9% and 86.3% at 1000 µg/mL. The IC50 values of 16.17 and 20.51 µg/mL against AChE and BChE were determined. Similarly, galanthamine caused inhibition of AChE and BChE, which was 11.3 and 16% at 7.8 µg/mL, whereas it was 88.7% and 91.3% at 1000 µg/mL, with IC50 values of 13.12 and 14.43 µg/mL. * p < 0.005 compared to galanthamine treatment.